Table 2 Phenotypic analysis of G6PD deficiency by CareStart™, and comparison of genotyping results between PCR–RFLP and the DiaplexC™ G6PD commercial kit (Solgent®)
From: G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
|  | RDT | PCR–RFLP | Solgent Kit | |||||
|---|---|---|---|---|---|---|---|---|
Normal | Deficient | B | A+ | A− a | B | A+ | A− | |
Male | 29 | 4 | 28 | – | 5 | 28 | 1 | 4 |
Female | 21 | 1 | 22 | – | – | 20 | – | 2 |
Total | 50 | 5 | 50 | – | 5 | 48 | 1 | 6 |